How many studies have been conducted on Tirzepatide?

BiohacksAI has indexed 293 PubMed studies on Tirzepatide, including 22 randomized controlled trials (RCTs). 50% of studies involve human subjects.

What are the main research areas for Tirzepatide?

The primary research domains for Tirzepatide are 🔥 Metabolic, ❤️ Cardiovascular, 🧬 Hormones. This is based on analysis of 293 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Tirzepatide

An analog of GASTRIC INHIBITORY POLYPEPTIDE and agonist of GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR and GLUCAGON-LIKE PEPTIDE-1 RECEPTOR used to enhance glycemic control of TYPE 2 DIABETES MELLITUS.

293+ PubMed studies analyzed · 22 RCTs · Evidence Score: 45.9

Research Domains

Tirzepatide has been studied across 14 research domains including 🔥 Metabolic, ❤️ Cardiovascular, 🧬 Hormones, 😴 Sleep, 🦠 Gut & Microbiome. The primary research focus is 🔥 Metabolic with 75% of studies addressing this area.

Loading evidence profile...

This evidence profile for Tirzepatide is generated deterministically from 293 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.